ESM1 and breast cancer: As shown in Figure 6E,F and Table S1B,C, a higher expression score of ESM-1 was associated with more metastatic (stage III/IV) (Figure 6F and Table S1B) and higher pathological grade (grade 2/3) (Figure 6E and Table S1C) of breast cancers.